• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性心房颤动患者中超极化激活的环核苷酸门控通道及微小RNA-1和-133的表达改变

Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation.

作者信息

Li Yao-Dong, Hong Yi-Fan, Yusufuaji Yueerguli, Tang Bao-Peng, Zhou Xian-Hui, Xu Guo-Jun, Li Jin-Xin, Sun Lin, Zhang Jiang-Hua, Xin Qiang, Xiong Jian, Ji Yu-Tong, Zhang Yu

机构信息

Department of Cardiology, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang Uyghur 830011, P.R. China.

出版信息

Mol Med Rep. 2015 Sep;12(3):3243-3248. doi: 10.3892/mmr.2015.3831. Epub 2015 May 25.

DOI:10.3892/mmr.2015.3831
PMID:26005035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4526032/
Abstract

Hyperpolarization-activated cyclic nucleotide-gated (HCN) cation channels mediate pacemaker currents in the atrium. The microRNA (miR) families miR-1 and miR-133 regulate the expression of multiple genes involved in myocardial function, including HCN channels. It was hypothesized that age‑dependent changes in HCN2, HCN4, miR‑1 and miR‑133 expression may contribute to age‑associated atrial fibrillation, and therefore the correlation between expression levels, among adult (≤65 years) and aged patients (≥65 years), and sinus rhythm was determined. Right atrial appendage samples were collected from 60 patients undergoing coronary artery bypass grafting. Reverse transcription-quantitative polymerase chain reaction (PCR) and western blot analyses were performed in order to determine target RNA and protein expression levels. Compared with aged patients with sinus rhythm, aged patients with atrial fibrillation exhibited significantly higher HCN2 and HCN4 channel mRNA and protein expression levels (P<0.05), but significantly lower expression levels of miR‑1 and miR‑133 (P<0.05). In addition, aged patients with sinus rhythm exhibited significantly higher expression levels of HCN2 and HCN4 channel mRNA and protein (P<0.05), but significantly lower expression levels of miR‑1 and ‑133 (P<0.05), compared with those of adult patients with sinus rhythm. Expression levels of HCN2 and HCN4 increased with age, and a greater increase was identified in patients with age‑associated atrial fibrillation compared with that in those with aged sinus rhythm. These electrophysiological changes may contribute to the induction of ectopic premature beats that trigger atrial fibrillation.

摘要

超极化激活的环核苷酸门控(HCN)阳离子通道介导心房的起搏电流。微小RNA(miR)家族miR-1和miR-133调节包括HCN通道在内的多个参与心肌功能的基因的表达。据推测,HCN2、HCN4、miR-1和miR-133表达的年龄依赖性变化可能与年龄相关的心房颤动有关,因此确定了成年(≤65岁)和老年患者(≥65岁)中这些表达水平与窦性心律之间的相关性。从60例接受冠状动脉旁路移植术的患者中采集右心耳样本。进行逆转录定量聚合酶链反应(PCR)和蛋白质印迹分析以确定靶RNA和蛋白质表达水平。与窦性心律的老年患者相比,心房颤动的老年患者表现出显著更高的HCN2和HCN4通道mRNA及蛋白质表达水平(P<0.05),但miR-1和miR-133的表达水平显著更低(P<0.05)。此外,与窦性心律的成年患者相比,窦性心律的老年患者表现出显著更高的HCN2和HCN4通道mRNA及蛋白质表达水平(P<0.05),但miR-1和miR-133的表达水平显著更低(P<0.05)。HCN2和HCN4的表达水平随年龄增加,与窦性心律的老年患者相比,年龄相关心房颤动患者的增加幅度更大。这些电生理变化可能有助于诱发触发心房颤动的异位早搏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/4526032/a8ce821d3f21/MMR-12-03-3243-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/4526032/9a2436fbeaec/MMR-12-03-3243-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/4526032/a8ce821d3f21/MMR-12-03-3243-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/4526032/9a2436fbeaec/MMR-12-03-3243-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8516/4526032/a8ce821d3f21/MMR-12-03-3243-g02.jpg

相似文献

1
Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation.年龄相关性心房颤动患者中超极化激活的环核苷酸门控通道及微小RNA-1和-133的表达改变
Mol Med Rep. 2015 Sep;12(3):3243-3248. doi: 10.3892/mmr.2015.3831. Epub 2015 May 25.
2
Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation.超极化激活环核苷酸门控(HCN)通道表达逆转与年龄相关性心房颤动之间的关联
Med Sci Monit. 2014 Nov 14;20:2292-7. doi: 10.12659/MSM.892505.
3
Chronic atrial fibrillation alters the functional properties of If in the human atrium.慢性心房颤动改变了人心房中 If 的功能特性。
J Cardiovasc Electrophysiol. 2013 Dec;24(12):1391-400. doi: 10.1111/jce.12212. Epub 2013 Jul 19.
4
Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.犬心力衰竭模型中的窦房结功能障碍与超极化激活(HCN)通道亚单位重塑
Cardiovasc Res. 2005 Jun 1;66(3):472-81. doi: 10.1016/j.cardiores.2005.02.011. Epub 2005 Mar 21.
5
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.miR-1/miR-133的下调有助于肥厚心脏中起搏通道基因HCN2和HCN4的重新表达。
J Biol Chem. 2008 Jul 18;283(29):20045-52. doi: 10.1074/jbc.M801035200. Epub 2008 May 5.
6
Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.在转基因心房颤动小鼠中,长期使用伊伐布雷定治疗可对抗超极化激活环核苷酸门控通道过表达。
J Cardiovasc Electrophysiol. 2019 Feb;30(2):242-252. doi: 10.1111/jce.13772. Epub 2018 Nov 5.
7
A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation.一种新型的转运缺陷型HCN4突变与早发性心房颤动相关。
Heart Rhythm. 2014 Jun;11(6):1055-1062. doi: 10.1016/j.hrthm.2014.03.002. Epub 2014 Mar 4.
8
Identification of Key Small Non-Coding MicroRNAs Controlling Pacemaker Mechanisms in the Human Sinus Node.鉴定控制人心房结起博机制的关键微小非编码 miRNAs。
J Am Heart Assoc. 2020 Oct 20;9(20):e016590. doi: 10.1161/JAHA.120.016590. Epub 2020 Oct 16.
9
Transcriptional control of pacemaker channel genes HCN2 and HCN4 by Sp1 and implications in re-expression of these genes in hypertrophied myocytes.Sp1对起搏通道基因HCN2和HCN4的转录调控及其在肥大心肌细胞中这些基因重新表达中的意义。
Cell Physiol Biochem. 2009;23(4-6):317-26. doi: 10.1159/000218178. Epub 2009 May 6.
10
The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.C 端 HCN4 变异型 P883R 改变通道特性,并作为心房颤动和结构性心脏病的遗传修饰因子。
Biochem Biophys Res Commun. 2019 Oct 29;519(1):141-147. doi: 10.1016/j.bbrc.2019.08.150. Epub 2019 Aug 31.

引用本文的文献

1
Epigenetic Mechanisms in Heart Diseases.心脏病中的表观遗传机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):38696. doi: 10.31083/RCM38696. eCollection 2025 Jul.
2
Epigenetic Drivers of Atrial Fibrillation: Mechanisms, Biomarkers, and Therapeutic Targets.心房颤动的表观遗传驱动因素:机制、生物标志物及治疗靶点
Int J Mol Sci. 2025 May 29;26(11):5253. doi: 10.3390/ijms26115253.
3
MicroRNAs in atrial fibrillation - have we discovered the Holy Grail or opened a Pandora's box?心房颤动中的微小RNA——我们是找到了圣杯还是打开了潘多拉魔盒?

本文引用的文献

1
Sick sinus syndrome: a review.病态窦房结综合征:综述。
Am Fam Physician. 2013 May 15;87(10):691-6.
2
Chronic atrial fibrillation alters the functional properties of If in the human atrium.慢性心房颤动改变了人心房中 If 的功能特性。
J Cardiovasc Electrophysiol. 2013 Dec;24(12):1391-400. doi: 10.1111/jce.12212. Epub 2013 Jul 19.
3
Exceptional stories of microRNAs. miRNA 的非凡故事。
Front Pharmacol. 2025 Feb 12;16:1535621. doi: 10.3389/fphar.2025.1535621. eCollection 2025.
4
Serum calcium-magnesium ratio at admission predicts adverse outcomes in patients with acute coronary syndrome.入院时血清钙镁比值可预测急性冠状动脉综合征患者的不良预后。
PLoS One. 2024 Nov 8;19(11):e0313352. doi: 10.1371/journal.pone.0313352. eCollection 2024.
5
Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation.通过生物信息学分析和实验验证鉴定慢性心房颤动中的miR-1和miR-499
Front Cardiovasc Med. 2024 Aug 16;11:1400643. doi: 10.3389/fcvm.2024.1400643. eCollection 2024.
6
miRNAs in Heart Development and Disease.miRNAs 在心脏发育和疾病中的作用。
Int J Mol Sci. 2024 Jan 30;25(3):1673. doi: 10.3390/ijms25031673.
7
MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment.MicroRNAs:心脏健康、疾病和治疗的中场球员。
Int J Mol Sci. 2023 Nov 11;24(22):16207. doi: 10.3390/ijms242216207.
8
The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives.肠道微生物组与心房颤动的相关性:病理生理学和治疗观点。
Mil Med Res. 2023 Nov 7;10(1):51. doi: 10.1186/s40779-023-00489-1.
9
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.微小 RNA 在多柔比星诱导的心脏毒性的诊断和治疗中的作用。
Biomolecules. 2023 Mar 20;13(3):568. doi: 10.3390/biom13030568.
10
Non-coding RNA and arrhythmias: expression, function, and molecular mechanism.非编码 RNA 与心律失常:表达、功能与分子机制。
Europace. 2023 Apr 15;25(4):1296-1308. doi: 10.1093/europace/euad047.
Exp Biol Med (Maywood). 2013 Apr;238(4):339-43. doi: 10.1258/ebm.2012.012251.
4
Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts.心室心肌中 HCN 通道表达增加导致小鼠衰竭心脏心律失常增强。
J Am Heart Assoc. 2013 May 24;2(3):e000150. doi: 10.1161/JAHA.113.000150.
5
New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels.心脏病学中的新治疗靶点:心力衰竭与心律失常:超极化激活的环核苷酸门控通道
Circulation. 2013 May 14;127(19):1986-96. doi: 10.1161/CIRCULATIONAHA.112.000145.
6
Changes in microRNAs expression are involved in age-related atrial structural remodeling and atrial fibrillation.miRNAs 表达的变化与年龄相关的心房结构重构和心房颤动有关。
Chin Med J (Engl). 2013;126(8):1458-63.
7
Hyperpolarization activated cation current (I(f)) in cardiac myocytes from pulmonary vein sleeves in the canine with atrial fibrillation.犬心房颤动肺静脉袖心肌细胞中的超极化激活阳离子电流(I(f))。
J Geriatr Cardiol. 2012 Dec;9(4):366-74. doi: 10.3724/SP.J.1263.2012.04161.
8
Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis.异搏定对肺静脉电活动的影响及对起搏电流和钙稳态的调节作用。
J Cardiovasc Electrophysiol. 2012 Feb;23(2):200-6. doi: 10.1111/j.1540-8167.2011.02173.x. Epub 2011 Sep 13.
9
Electroanatomic remodelling of the pulmonary veins associated with age.肺静脉的电重构与年龄相关。
Europace. 2012 Jan;14(1):46-51. doi: 10.1093/europace/eur275. Epub 2011 Aug 18.
10
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.心肌梗死后大鼠长期应用伊伐布雷定可对抗 F 通道过表达。
Br J Pharmacol. 2012 Mar;165(5):1457-66. doi: 10.1111/j.1476-5381.2011.01627.x.